However, the directionally discordant effects we observed of CD40 on rheumatoid arthritis versus multiple sclerosis and IBD raises the possibility of triggering other forms of immune-mediated diseases as a side effect of anti-CD40 therapy. The gene discussed is CD40; the disease is rheumatoid arthritis.